GlassScriptPhysician profile
Scott M Henslee
NPI 1538251319
$17,265.59
in general payments reported to CMS, 2019-2025
39 companies · $2,645 in 2025
The $2,645 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,155 · 2020: $1,600 · 2021: $1,926 · 2022: $2,385 · 2023: $2,870 · 2024: $3,684 · 2025: $2,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,729 · Education: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,728.79 |
| Education | $470.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,404.37 | 2019-2025 | |
| Janssen Biotech, INC. | $2,908.94 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $1,037.95 | 2020-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $994.64 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $933.00 | 2019-2025 | |
| Amgen INC. | $917.44 | 2019-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $895.63 | 2022-2025 | Sotyktu |
| Ucb, INC. | $840.70 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $768.20 | 2019-2025 | Nemluvio, Aklief, Twyneo |
| Pfizer INC. | $678.26 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $486.28 | 2019-2025 | Siliq, Duobrii, Targretin |
| Sun Pharmaceutical Industries INC. | $472.91 | 2020-2025 | Ilumya, Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $439.92 | 2019-2025 | |
| Leo Pharma INC. | $384.43 | 2019-2025 | Adbry, Anzupgo |
| Mayne Pharma Commercial LLC | $274.60 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Henslee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.